Homestead Advisers Corp Acquires 33,900 Shares of GE HealthCare Technologies Inc. $GEHC

Homestead Advisers Corp lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,025,700 shares of the company’s stock after purchasing an additional 33,900 shares during the period. GE HealthCare Technologies comprises 1.8% of Homestead Advisers Corp’s holdings, making the stock its 23rd biggest position. Homestead Advisers Corp’s holdings in GE HealthCare Technologies were worth $77,030,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Godsey & Gibb Inc. bought a new stake in GE HealthCare Technologies during the 3rd quarter valued at $26,000. E Fund Management Hong Kong Co. Ltd. lifted its stake in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the last quarter. Allianz SE boosted its position in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares in the last quarter. Oakworth Capital Inc. boosted its position in GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after purchasing an additional 394 shares in the last quarter. Finally, Gladwyn Financial Advisors Inc. purchased a new position in GE HealthCare Technologies in the second quarter valued at about $34,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 4.8%

NASDAQ:GEHC opened at $82.58 on Thursday. The company has a market capitalization of $37.62 billion, a P/E ratio of 17.06, a PEG ratio of 2.38 and a beta of 1.08. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm has a fifty day simple moving average of $82.68 and a 200-day simple moving average of $77.47.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the firm earned $1.45 EPS. The firm’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

Key Stories Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 beats and guidance: GEHC posted Q4 EPS $1.44 vs. $1.40 consensus and revenue $5.7B vs. $5.6B; it set FY‑2026 EPS guidance of $4.95–$5.15 (above consensus). Investors view the results and guidance as evidence of continued demand. Business Wire: Q4 & FY Results
• Positive Sentiment: Analyst upgrade/policy: BTIG raised its price target to $91 and kept a “buy” rating, giving additional buy‑side validation and supporting upside. Street Insider: BTIG PT Raise
• Positive Sentiment: Regulatory/product win: GEHC won FDA clearance and CE mark for the Allia Moveo mobile C‑arm (AI guidance, compact design), enabling commercialization and early global installs — a potential growth driver for Imaging/PDx. Zacks: FDA clearance for Allia Moveo
• Neutral Sentiment: Full earnings details and call transcript are available for deeper read — useful for modeling revenue mix and margin assumptions. Seeking Alpha: Q4 Earnings Transcript
• Negative Sentiment: Margin pressure and lower profit: Net margin declined and reported profit fell despite higher revenue; Zacks and WSJ cite tariffs, an unfavorable product mix and ongoing investments as headwinds that could weigh on near‑term profitability. Zacks: Net margin falls WSJ: Lower profit despite revenue

Analysts Set New Price Targets

GEHC has been the subject of several analyst reports. Bank of America increased their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. Piper Sandler increased their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Morgan Stanley set a $85.00 price objective on GE HealthCare Technologies in a research report on Wednesday. Finally, UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their target price for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $91.33.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.